ARCHIVES

Lasagna Committee Report Advocates Faster Drug approval, Insurance Coverage For Investigational Drugs, Ancillary Costs

This article is from The Cancer Letter archive.

Vol. 16 No. 34 | September 7, 1990

Download PDF Visit The Full Archive

Related Articles

Weicker Ready To Fight for Increased NCI, NIH Funding, Objects to Limits On Grants, Positions

March 14, 1986

Immune Systems Don’t Stop, Causing Fatigue For Survivors

May 26, 2006

In Brief: DRCA Board Split On Guidelines For CCOP Remains Unresolved; Chop Implementation Talks Starting

December 4, 1981

Letter to The Editor: IOM Panel Urges Greater Integration Of Research

February 12, 1999

LabCorp Marketing Of Ovarian Cancer Test Unlawful, FDA Says In Warning Letter.

October 17, 2008

NCI Budget of $1.4 Billion Seems Assured, Barring GRH Cut, Veto; Organ Systems Renewal Confirmed

October 17, 1986